Blood Glucose Test: Normal Ranges, High & Low Levels, and What Your Results Mean

Quick answer: For nonpregnant adults, a normal fasting plasma glucose level is generally 70–99 mg/dL (3.9–5.5 mmol/L). Under American Diabetes Association criteria, fasting glucose of 100–125 mg/dL (5.6–6.9 mmol/L) indicates prediabetes, while 126 mg/dL (7.0 mmol/L) or higher meets the diagnostic threshold for diabetes, with confirmatory testing required in the absence of unequivocal hyperglycemia. HbA1c provides a longer-term view of glucose exposure, with diabetes diagnosed at 6.5% (48 mmol/mol) or higher. Results should always be interpreted according to the type of test, clinical circumstances, and applicable guidelines.

What Is a Blood Glucose Test?
A blood glucose test measures the concentration of glucose (sugar) in your blood at a specific moment. Glucose is one of the body's main energy sources, and its blood level is tightly regulated by insulin and other hormones. When this regulation fails — either chronically (diabetes) or acutely (stress, medication, illness) — glucose levels move outside the normal range.
Doctors order glucose tests to screen for and diagnose diabetes and prediabetes, monitor known diabetes, investigate symptoms such as excessive thirst or unexplained weight loss, and manage diabetes during pregnancy, hospitalization, or surgery.

The Main Types of Glucose Tests
1. Fasting plasma glucose (FPG). Measured after at least 8 hours without food (water is allowed). This is the standard screening and diagnostic test.

2. Random plasma glucose (RPG). Measured at any time, regardless of when you last ate. There is no universal "normal ceiling" for a random measurement — food, time of day, and activity all influence it. Its diagnostic role is specific: a random value of 200 mg/dL (11.1 mmol/L) with classic symptoms (frequent urination, intense thirst, unexplained weight loss) is diagnostic of diabetes without further confirmation.

3. Oral glucose tolerance test (OGTT). Fasting glucose, then a glucose drink, then a measurement at 2 hours. The 2-hour OGTT identifies more people with prediabetes and diabetes than fasting glucose or HbA1c alone. Importantly, the diagnostic thresholds below apply to this standardized test — not to glucose measured after ordinary meals.

4. HbA1c (glycated hemoglobin). Reflects your average blood glucose over approximately 2–3 months. It requires no fasting and is used for both diagnosis and long-term monitoring. Its limitation: HbA1c does not directly capture daily glucose fluctuations or hypoglycemic episodes.

Gestational diabetes testing uses the OGTT framework but differs by country and strategy. In the United States, a one-step 75-g OGTT based on IADPSG criteria, or a two-step approach involving a 50-g glucose challenge followed — when indicated — by a 100-g OGTT using Carpenter–Coustan criteria, may be used. In the United Kingdom, NICE recommends a 75-g OGTT with its own diagnostic thresholds.

Continuous Glucose Monitoring (CGM): Monitoring, Not Diagnosis
CGM deserves a separate mention because it is often confused with a diagnostic test. A CGM sensor measures glucose in interstitial fluid every 1–5 minutes and is used to monitor and optimize treatment in people with diabetes — not to diagnose it. Its metrics (Time in Range, Time Below Range, Glucose Management Indicator) complement HbA1c, and the 2026 ADA Standards formally recognize CGM metrics as a valid tool for glycemic assessment alongside A1c. Diagnostic decisions still rely on plasma glucose measurements and HbA1c.

Normal Blood Glucose Ranges (People Without Diabetes)

• Fasting (8+ hours without food): 70–99 mg/dL (3.9–5.5 mmol/L)
• 2-hour post-OGTT glucose: below 140 mg/dL (7.8 mmol/L) — this cutoff applies specifically to the standardized 75-g OGTT; there is no validated diagnostic threshold for glucose measured after ordinary mixed meals
• HbA1c: below 5.7% (below 39 mmol/mol)

Understanding Prediabetes: Ranges, Risk, and What You Can Change

• Fasting glucose (impaired fasting glucose, IFG): 100–125 mg/dL (5.6–6.9 mmol/L) — US (ADA); 110–125 mg/dL (6.1–6.9 mmol/L) — WHO
• 2-hour OGTT (impaired glucose tolerance, IGT): 140–199 mg/dL (7.8–11.0 mmol/L)
• HbA1c: 5.7–6.4% (39–47 mmol/mol) — US (ADA); 6.0–6.4% (42–47 mmol/mol) — UK (NICE)

Prediabetes is a major risk factor for type 2 diabetes and cardiovascular disease. Progression risk can be substantially reduced — in the Diabetes Prevention Program (DPP), an intensive structured lifestyle intervention lowered the relative incidence of type 2 diabetes by 58% compared with placebo over a mean follow-up of 2.8 years, a population-level result rather than a guaranteed outcome for any individual. ADA recommends a minimum 5–7% weight loss (if overweight) and 150+ minutes of weekly activity; greater weight loss may add further benefit. Recheck at least annually, adjusting frequency to individual risk.

Diabetes Diagnostic Thresholds
Diabetes may be diagnosed using any one of the following criteria:

1. HbA1c ≥ 6.5% (≥ 48 mmol/mol), or
2. Fasting plasma glucose ≥ 126 mg/dL (≥ 7.0 mmol/L), or
3. 2-hour OGTT glucose ≥ 200 mg/dL (≥ 11.1 mmol/L), or
4. Random plasma glucose ≥ 200 mg/dL (≥ 11.1 mmol/L) with classic symptoms (polyuria, polydipsia, unexplained weight loss)

Confirmation is normally required — by repeat testing, or by two abnormal results from different tests (e.g., elevated A1c and FPG measured together) — except when unequivocal hyperglycemia is present, such as classic symptoms with a random plasma glucose ≥200 mg/dL or a hyperglycemic crisis.

⚠️ One mildly elevated result without symptoms is not a diagnosis. Acute illness, infection, surgery, stress, poor sleep, and medications such as glucocorticoids can temporarily raise glucose.

US (ADA) vs UK (NICE) Criteria: What Differs

NICE uses these glycemic ranges within a broader type 2 diabetes risk-assessment pathway that also considers clinical risk factors.

Terminology note: "Impaired fasting glucose" (IFG) is a WHO-defined term meaning 6.1–6.9 mmol/L — a narrower range than NICE's broader "increased risk" band starting at 5.5 mmol/L. The two are related but not identical.
Practical takeaway: a UK reader with HbA1c of 5.8% does not meet NICE's HbA1c high-risk threshold (though NICE weighs other clinical risk factors too) and may be labeled "prediabetic" by US criteria — one more reason results must be read against the guideline your own clinician follows.
Glycemic Targets for People Living With Diabetes
Diagnostic thresholds and treatment targets serve different purposes. While diagnostic thresholds for diabetes are broadly aligned across major guidelines, definitions of intermediate hyperglycemia and gestational diabetes can differ. Treatment targets are individualized. According to the ADA Standards of Care in Diabetes—2026, for many nonpregnant adults:

• HbA1c: below 7.0% (below 53 mmol/mol) — a lower goal (below 6.5%) may suit people in good health with low hypoglycemia risk; less stringent goals are appropriate for frailty, cognitive impairment, or severe comorbidities
• Fasting / pre-meal glucose: 80–130 mg/dL (4.4–7.2 mmol/L) — the ADA raised the lower limit from 70 to 80 mg/dL in 2015 based on evidence
• Peak post-meal glucose (1–2 h after the start of a meal): below 180 mg/dL (10.0 mmol/L)
• Time in Range (CGM, 70–180 mg/dL): above 70% — this aligns with an HbA1c of approximately 7%
• Time below 70 mg/dL: below 4%; time below 54 mg/dL: below 1% — if these targets are not met, the treatment plan should be reviewed and modified or de-intensified as appropriate

During pregnancy (ADA 2026): fasting below 95 mg/dL, 1-hour post-meal below 140 mg/dL, 2-hour post-meal below 120 mg/dL (6.7 mmol/L). UK (NICE NG3) targets are similar but slightly stricter at 2 hours: below 6.4 mmol/L.

Older adults: for those with complex or intermediate health status, a more permissive goal of 50% time in range (70–180 mg/dL) is accepted, with time below 70 mg/dL not exceeding 1% (15 minutes per day).

Hospital and surgery settings: the ADA 2026 Standards recommend a preoperative HbA1c goal below 8% within 3 months of elective surgery and a perioperative glucose range of 100–180 mg/dL

High Blood Glucose: How to Interpret Elevated Results
140–180 mg/dL (7.8–10.0 mmol/L) — interpretation depends on timing and context. A fasting value in this range exceeds the diabetes diagnostic threshold (≥126 mg/dL) and warrants prompt confirmatory testing. Post-meal readings here may occur after large, high-glycemic meals but cannot diagnose impaired glucose tolerance — that requires a standardized 75-g OGTT.

180–250 mg/dL (10.0–13.9 mmol/L) — clearly elevated. Persistent elevations warrant assessment using validated diagnostic tests. In hospitals, the ADA defines hyperglycemia as any glucose above 140 mg/dL, with persistent values ≥180 mg/dL on two occasions within 24 hours prompting treatment initiation.
If you are at risk of DKA, check ketones when symptoms or precipitating factors are present — particularly when glucose exceeds 200 mg/dL (11.1 mmol/L). This applies especially to people with type 1 diabetes, those who have missed insulin doses, anyone during acute illness, and people taking SGLT2 inhibitors, among whom euglycemic DKA (glucose below 200 mg/dL) is a recognized risk. DKA is confirmed by ketosis plus metabolic acidosis, not by the glucose number alone; glucose this high with ketones and acidosis is a medical emergency.

Above 600 mg/dL (33.3 mmol/L) — possible HHS. A plasma glucose level of 600 mg/dL or higher may indicate hyperosmolar hyperglycemic state. Diagnosis also requires hyperosmolarity (effective serum osmolality >300 mOsm/kg or total serum osmolality >320 mOsm/kg), without significant ketonemia or acidosis. Suspected HHS is a medical emergency, especially in older adults with type 2 diabetes.
Causes of transient (non-diabetic) hyperglycemia: acute illness, surgery, trauma, pancreatitis, Cushing's syndrome, thyroid disorders, and medications (glucocorticoids, some antipsychotics).

Low Blood Glucose (Hypoglycemia): the International 3-Level Classification
For people on glucose-lowering therapy, hypoglycemia is defined as glucose below 70 mg/dL (3.9 mmol/L) — the threshold where counter-regulatory responses activate, often before symptoms appear.

• Level 1 — 54–69 mg/dL (3.0–3.8 mmol/L): alert threshold. Treat immediately with ~15 g of fast-acting carbohydrate and recheck in 15 minutes (the "15-15 rule").
• Level 2 — below 54 mg/dL (below 3.0 mmol/L): clinically significant. Neuroglycopenic symptoms may begin: confusion, slurred speech, behavioral change. Repeated asymptomatic Level 2 episodes warrant evaluation for impaired hypoglycemia awareness — a single measurement does not establish it.
• Level 3 — any value: severe event. Altered mental or physical status requiring assistance from another person. For an unconscious person who cannot swallow safely: do not give food or drink — call emergency services and administer glucagon if available.

Early (adrenergic) symptoms: shakiness, sweating, rapid heartbeat, irritability, anxiety, intense hunger, tingling. Late (neuroglycopenic) symptoms: confusion, blurred vision, seizures, loss of consciousness.

Note: these thresholds and treatment rules apply to people receiving glucose-lowering therapy. In people without diabetes, clinically significant hypoglycemia is assessed by Whipple's triad: symptoms + a low measured glucose + relief of symptoms after glucose normalization.

5 Reasons Your Result May Be Misleading

1. "Normal" fasting glucose does not necessarily exclude diabetes. Some individuals meet diagnostic criteria based on HbA1c or a 2-hour OGTT despite having fasting glucose below the diagnostic threshold.
2. HbA1c has blind spots. Hemoglobin variants, recent blood transfusion, and chronic kidney disease can affect results in either direction; hemolytic anemia and conditions shortening red blood cell lifespan falsely lower it, while iron-deficiency anemia often falsely raises it.
3. Different devices measure different things. Modern finger-stick meters report plasma-calibrated values (closely comparable to lab plasma glucose), while CGM measures interstitial fluid with a 5–15 min lag. They are not perfectly interchangeable.
4. Circadian effects are modest in healthy people. The dawn phenomenon meaningfully raises morning glucose mainly in diabetes; in healthy individuals, compensatory insulin secretion typically prevents it.
5. Confirmation is built into the criteria. Except for unequivocal symptomatic hyperglycemia, diagnostic thresholds require confirmation — a single lab value is a signal, not a verdict.

What to Do With Your Results

• FPG 100–125 mg/dL (ADA) or A1c 5.7–6.4%: prediabetes / increased risk — begin lifestyle intervention now; recheck at least annually.
• FPG ≥126, A1c ≥6.5%, or OGTT 2-h ≥200: see a physician promptly for confirmation, diabetes type classification, and treatment planning.
• Random glucose ≥200 with classic symptoms: prompt evaluation — hyperglycemic crises such as DKA and HHS can develop over widely varying timeframes, and urgency depends on symptoms and clinical condition.
• Recurrent glucose <70 mg/dL (on therapy): discuss regimen adjustment with your care team.
• Hypoglycemia without diabetes medication: request evaluation for Whipple's triad–confirmed hypoglycemia (insulinoma, adrenal insufficiency, reactive hypoglycemia).
• Before elective surgery: ask about the ADA 2026 preoperative target of HbA1c <8% and perioperative glucose of 100–180 mg/dL.

Frequently Asked Questions
What is a normal blood sugar level by age? For healthy adults, fasting 70–99 mg/dL and OGTT 2-hour glucose below 140 mg/dL regardless of age. For people with diabetes, targets are individualized: stricter for healthy younger adults, more permissive for older adults and those with frailty or comorbidities.

Is 120 mg/dL fasting normal or high?
It falls in the prediabetes zone (100–125 mg/dL / 5.6–6.9 mmol/L). One reading requires confirmation, but it is an early, actionable warning sign.

Is 140 mg/dL after eating normal?
There is no simple yes/no — glucose after an ordinary meal depends on what and how much you ate and when you measured. The 140 mg/dL cutoff applies to the standardized 2-hour OGTT: below 140 is normal, 140–199 indicates impaired glucose tolerance. After a regular meal, a one-off reading above 140 is not diagnostic of anything.

What glucose level is an emergency?
There is no single glucose level that defines every diabetic emergency. Suspected DKA requires urgent medical assessment when ketosis and symptoms of metabolic decompensation are present and can occur even with glucose below 200 mg/dL. Severe hypoglycemia requiring assistance is also an emergency. Glucose ≥600 mg/dL together with hyperosmolarity may indicate HHS and requires emergency treatment. A glucose below 54 mg/dL with symptoms in a conscious person who can swallow requires immediate self-treatment with fast-acting carbohydrate — not automatically an ambulance.

Can stress raise blood glucose temporarily?
Yes — acute physical or psychological stress raises glucose via cortisol and adrenaline. This is why abnormal results should be confirmed under stable conditions.
Key Takeaways

• Normal fasting: 70–99 mg/dL · normal 2-h OGTT: <140 mg/dL · normal A1c: <5.7% (ADA)
• Increased risk / prediabetes: fasting 100–125 mg/dL (ADA) or 5.5–6.9 mmol/L (NICE risk band); A1c 5.7–6.4% (ADA) or 6.0–6.4% (NICE)
• Diabetes: fasting ≥126, A1c ≥6.5%, OGTT 2-h ≥200, or symptomatic random ≥200 — confirmatory testing required in the absence of unequivocal hyperglycemia
• Treat low immediately (if on therapy): <70 mg/dL; below 54 mg/dL is clinically significant
• Treat high urgently: DKA is a diagnosis of ketosis + acidosis (possible even below 200 mg/dL with SGLT2 inhibitors); >600 mg/dL with hyperosmolarity and no significant ketosis is HHS territory
• Targets are personal: the ADA 2026 Standards stress individualization by age, pregnancy, frailty, and hypoglycemia risk — the harms of overtreatment must never exceed its benefits

Sources & References

1. American Diabetes Association. Standards of Care in Diabetes—2026, Sections 2, 3, 6, 15, and 16. Diabetes Care 2026;49(Suppl 1).
2. NICE. NG3: Diabetes in pregnancy; PH38: Type 2 diabetes — prevention in people at high risk; NG28: Type 2 diabetes in adults.
3. WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia.
4. Battelino T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42(8):1593–1603.
5. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.

This article is for educational purposes and reflects current international guidelines as of October 2026. It does not replace individual medical advice — always discuss your results with a qualified healthcare provider.